Junwei Cai

412 citations
24 papers · 301 indexed · h-index 9
Topics
Epigenetics and DNA Methylation (3 papers)Immune Response and Inflammation (3 papers)Immune cells in cancer (3 papers)

In The Last Decade

Junwei Cai

22 papers receiving 299 citations

Peers

Junwei Cai
Comparison fields: 5 of 82
  • Molecular Biology 134
  • Immunology 84
  • Cancer Research 52
  • Epidemiology 47
  • Surgery 27
Replace Fuli Shi with:
Fuli Shi China
Yongquan Pan China
Rou Zhou China
Enas Samir Nabih Egypt
Xinggu Lin China
Hongyan Tian China
Lucia S. Graham United States
Yejiang Zhou China
Linnea Hases Sweden
Junwei Cai relative to Fuli Shi China Fuli Shi's profile →
Citations per field
00.5×5.4×
Fuli Shi · 1×
Citations per year

Countries citing papers authored by Junwei Cai

Since Specialization
Citations

This map shows the geographic impact of Junwei Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junwei Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junwei Cai more than expected).

Fields of papers citing papers by Junwei Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junwei Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junwei Cai. The network helps show where Junwei Cai may publish in the future.

Co-authorship network of co-authors of Junwei Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Junwei Cai. A scholar is included among the top collaborators of Junwei Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junwei Cai. Junwei Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 7
3 3
4 6
5 6
6 4
7 1
8 1
9 8
10 25
11 1
12 33
13 1
14 25
15
Comparative persistence with antihyperglycemic agents (AHA) used to treat type 2 diabetes mellitus (T2DM) in the real world
1
16 109
17 18
18 9
19
Analysis of factors associated with nosocomial infection in lung cancer patients after surgical treatment
1
20
A Mathematical Model of Arranging the Game Schedule for Single Round Robin
0

About Junwei Cai

Junwei Cai is a scholar working on Immunology, Complementary and alternative medicine and Ophthalmology, having authored 24 papers that have together received 301 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (3 papers), Immune Response and Inflammation (3 papers) and Immune cells in cancer (3 papers). The work is most often cited by research in Immunology (84 citations), Cancer Research (52 citations) and Molecular Biology (134 citations). Junwei Cai has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Xuefeng Li, Wenhong Cao, Longying Zha, Zhenqi Liu, Limei Mao, Xinwei Chu, Suxia Sun, Hong Deng, Jinghua Liu and Shuqi Zhao. Their work appears in journals such as PLoS ONE, Scientific Reports and BMC Bioinformatics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026